The Long Run with Luke Timmerman

Timmerman Report
undefined
Feb 9, 2021 • 1h 9min

Ep86: Sek Kathiresan on a Gene-Edited Single Shot for Heart Disease

Sekar Kathiresan, co-founder and CEO of Verve Therapeutics, on a gene edited single shot for cardiovascular disease.
undefined
Jan 20, 2021 • 47min

Ep85: Luhan Yang on CRISPR Editing for Organ Transplants

Luhan Yang, CEO of Qihan Bio, on CRISPR editing for organ transplants.
undefined
Dec 22, 2020 • 1h 9min

Ep84: Steve Paul on Treatments for Mental Health

Steve Paul, CEO of Karuna Therapeutics, on neuropsychiatric drug development.
undefined
Dec 14, 2020 • 58min

Ep83: David Lee on Impact in Pharmaceuticals

David Lee, CEO of Servier Pharma, on a nonprofit model.
undefined
Nov 23, 2020 • 59min

Ep82: Andrew Farnum on Medicines From Unusual Traits

Andrew Farnum, CEO of Variant Bio, on drug discovery based on rare genetic traits.
undefined
Nov 12, 2020 • 1h 7min

Ep81: Simba Gill on Microbiome Therapies

Simba Gill, CEO of Evelo Biosciences, on microbiome therapies.
undefined
Oct 28, 2020 • 52min

Ep80: Peter Kolchinsky on Pharma's Soul

Peter Kolchinsky of RA Capital on making drugs affordable, and keeping incentives for drug discovery.
undefined
Oct 26, 2020 • 1h 10min

Ep79: Daphne Koller on Machine Learning for Drug Discovery

Daphne Koller, CEO of insitro, on machine learning for drug discovery
undefined
Oct 13, 2020 • 1h 6min

Ep78: Pearl Huang on Exoneural Cancer Biology

Pearl Huang, CEO of Cygnal Therapeutics, on Exoneural Cancer Biology
undefined
Sep 29, 2020 • 1h 21min

Ep77: Jennifer Petter on Drugging RNA Targets

Jennifer Petter, CSO of Arrakis Therapeutics, on small molecule drugs for RNA targets

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app